Dynasil’s RMD Subsidiary Awarded $4 Million in Technology Development Grants by U.S. Department of Energy

WATERTOWN, Mass. -- Dynasil Corporation of America (NASDAQ: DYSL) today announced that its contract research subsidiary, RMD Inc., has received four grants totaling $4.0 million under the U.S. Department of Energy's Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Programs. "RMD's world-class research in nuclear detection continues to be on the cutting [...]

PBL Assay Science announces ultra-sensitive assay services to measure biomolecules in human serum or plasma

PISCATAWAY, N.J. -- PBL Assay Science announces the expansion of its assay services portfolio to include 38 different ultra-sensitive biomolecule assays using the Singulex® Erenna® Immunoassay technology. Based on an innovative single-molecule counting (SMC) technology, these services are designed to provide sub-picogram per ml sensitivity for analytes in human serum or plasma. The background reduction [...]

Microtrac obtains US Food and Drug Administration (FDA) Establishment Registration for Particle Analysis Services

Microtrac, the global pioneer of instrumentation and services for particle characterization, is pleased to announce that their Particle Analysis Laboratory (PAL), located in Largo, Florida is registered with the US Food and Drug Administration under the “FDA Drug Establishment Registration” program. With the PAL having acquired FDA registration, Microtrac will accept pharmaceutical ingredients, including those [...]

Leading EU and UK Pesticide Testing Labs Collaborate with Thermo Fisher Scientific

RUNCORN, UK – In efforts to ensure safe and healthy food, two leading European food testing laboratories are collaborating with Thermo Fisher Scientific at the company’s new Pesticide Analysis Center of Excellence to improve methods for detecting and measuring pesticide residues in food. The European Union Reference Laboratories (EURL) for Residues of Pesticides in Fruits [...]

Transgenomic Appoints Stephen R. Miller as Senior Vice President and General Manager of Patient Testing Business Unit

OMAHA, Neb. -- Transgenomic, Inc. (OTCBB: TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through diagnostic tests as well as clinical and research services, today announced that Stephen R. Miller has been named Senior Vice President and General Manager, Patient Testing. Mr. Miller brings over 22 years of experience [...]

QIAGEN announces third co-development program for companion diagnostics paired with Lilly’s investigational cancer compounds

Hilden, Germany, and Germantown, Maryland – QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) today announced an agreement with Eli Lilly and Company (NYSE: LLY) to develop and commercialize a molecular companion diagnostic paired with a novel Lilly oncology compound. This is the third co-development project by QIAGEN and Lilly to create companion diagnostics, which are [...]

Agilent Technologies Introduces Enhanced Electronic Laboratory Notebook

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced the latest version of its electronic laboratory notebook (ELN) software, OpenLAB ELN 4.2. This newly enhanced software enables scientists and laboratory managers to quickly and easily capture, reuse, manage and share scientific results obtained from virtually any analytical software application. "With this new revision, [...]

Copley Scientific showcases new products for smarter inhaled product testing at DDL 24

Nottingham, UK: New products for smarter, more representative inhaled product testing will be on display at the Copley Scientific stand at Drug Delivery to the Lungs 24 (DDL 24, 11-13 December 2013, Edinburgh International Conference Centre, Scotland). The latest additions to the Copley Scientific range help to make inhaled testing more efficient and improve the [...]

IBA Completes the Sale of Cisbio Bioassays

Louvain-la-Neuve, Belgium - IBA (Ion Beam Applications S.A., EURONEXT), the world's leading provider of proton therapy solutions for the treatment of cancer, today announces the closing of the sale of 100% of its Business Unit Cisbio Bioassays. Today's closing has led to a payment to IBA of EUR 16.3 million. In addition, the contract includes [...]

Agilent Technologies Oligo Design Tool Expanded to Include Custom CGH, ChIP-on-Chip, DNA Methylation Array Capabilities

SANTA CLARA, Calif. -- Agilent Technologies Inc. (NYSE: A) today introduced an enhanced version of SureDesign software enabling clinical researchers to design customized CGH (comparative genomic hybridization), ChIP-on-chip (chromatin immunoprecipitation), and DNA methylation microarrays for molecular cytogenomics and other applications. The new version of SureDesign replaces these microarray applications for the eArray platform and provides [...]

Access IBO on Knowledge Center